dna 23andme - Search News

Order byBest matchMost fresh

23andMe, Regeneron and genetic testing

23andMe sale reveals what your genetic data is worth. It’s less than you think

The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK made a $300 million dollar deal with 23andMe which allowed it to acquire the genetic data of 5 million people. That means the value of each customer’s data was about $60 at that time.

· 15h

Regeneron buying 23andMe; What happened to 23andMe? Should I delete 23andMe data?

· 2d · on MSN

Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million

· 1d

Struggling DNA testing firm 23andMe to be bought for $256m

23andMe says it has entered into an agreement to be acquired by Regeneron Pharmaceuticals for $256m (£192m).

· 1d

23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction

Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million

· 1d

23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private

Regeneron said Monday it will “prioritize the privacy, security and ethical use” of the personal DNA data from about 15 million people in a $256 million deal to acquire assets of bankrupt 23andMe Hold...

· 1d

Biotechnology company Regeneron buying 23andMe for $256 million

· 1d

Bankrupt DNA testing company 23andMe to be bought by Regeneron

23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.

Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles including a data breach.

Timeline: 23andMe’s Journey From DNA Testing Pioneer to Bankruptcy Sale

What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.

1don MSN

Bankrupt DNA Company 23andMe Expected to Be Purchased for $256M: What Users Need to Know About Their Privacy

Genetics company 23andMe is expected to be purchased by Regeneron Pharmaceuticals, according to announcements shared by both companies Both companies vowed that Regeneron is committed to comply with 23andMe's privacy policies,

23andMe to Be Bought by Biotech Company for $256 Million

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.

12hon MSN

Deadline for 23andMe data breach claims announced

RALEIGH, N.C. (WITN) - The deadline to file claims against a DNA testing company has been announced. In October 2023, 23andMe suffered a massive data breach that potentially compromised the private genetic information of millions of people.